C2N Diagnostics Employee Directory

C2N Diagnostics corporate office is located in 20 S Sarah St, Saint Louis, Missouri, 63108, United States and has 51-200 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Engineering & Technical

23

Operations

10

Medical & Health

9

Sales

8

Finance

4

Information Technology

3

Legal

3

Key Employees of C2N Diagnostics

  • RR
    United States flag for contact location.
    Rachel Resnick

    Controller

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

C2N Diagnostics Global Presence

globalPresence illustration
North America51-200
Asia1-10

Index of contact profiles from C2N Diagnostics

Hundreds of professionals searching for C2N Diagnostics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
1234

Former Employees at C2N Diagnostics

Explore people who held key positions, contributed to C2N Diagnostics's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Missouri, United States

Frequently Asked Questions Regarding C2N Diagnostics Employees

How many employees does C2N Diagnostics have?
C2N Diagnostics has 51-200 employees
Who are C2N Diagnostics key employees?
Some of C2N Diagnostics key employees are Rachel Resnick
Where is C2N Diagnostics located?
C2N Diagnostics’s headquarters are located at 20 S Sarah St, Saint Louis, Missouri, 63108, United States
How do I contact C2N Diagnostics?
C2N Diagnostics Contact Info: Phone number: (877) 226-3424 Website: www.c2ndiagnostics.com
What does C2N Diagnostics do?

C2N Diagnostics (www.c2ndiagnostics.com) was formed by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, MO and LifeTech Research, a technology research and venture development firm (www.lifetechresearch.com). C2N is commercializing a suite of biomarker tests to enable early det... ection of debilitating neurodegenerative disorders before symptom onset, facilitate drug discovery, and enhance clinical drug development at lower risk and cost. Besides its biomarker platform, C2N is also developing therapeutics for neurodegenerative disorders. In March 2015, C2N formed a global partnership with AbbVie to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders. AbbVie is currently conducting phase 2 trials with the lead candidate ABBV-8E12 in Alzheimer's disease and Progressive Supranuclear Palsy.Read More

Is C2N Diagnostics a public company?
C2N Diagnostics is private company therefore does not currently have an official ticker symbol
See more information about C2N Diagnostics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.